A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Seagen Inc.
Eli Lilly and Company
SOFIE
Jazz Pharmaceuticals
Aurigene Discovery Technologies Limited
Aurigene Discovery Technologies Limited
Eli Lilly and Company
Genentech, Inc.
Astellas Pharma Inc
AbbVie
Eli Lilly and Company
Merck Sharp & Dohme LLC
AstraZeneca
Hoffmann-La Roche
OncoC4, Inc.
Taiho Oncology, Inc.
Jazz Pharmaceuticals
Pfizer
Revolution Medicines, Inc.
Bayer
USWM, LLC (dba US WorldMeds)
Pfizer
Ferronova Pty Ltd
Merck Sharp & Dohme LLC
Amgen
Arcus Biosciences, Inc.
SystImmune Inc.
Merck Sharp & Dohme LLC
Sutro Biopharma, Inc.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Neonc Technologies, Inc.
ViroMissile, Inc.
Seagen Inc.
Qurient Co., Ltd.
AstraZeneca
Intima Bioscience, Inc.
Revolution Medicines, Inc.
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Prelude Therapeutics
SystImmune Inc.
Daiichi Sankyo
Takeda
Lumicell, Inc.
Perspective Therapeutics
Second Life Therapeutics
Shanghai Henlius Biotech
Phrontline Biopharma
Novartis
Var2 Pharmaceuticals